A critical role of interleukin-1 in preterm labor
Date
2016
Authors
Nadeau-Vallée, M.
Obari, D.
Quiniou, C.
Lubell, W.D.
Olson, D.M.
Girard, S.
Chemtob, S.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Cytokine and Growth Factor Reviews, 2016; 28:37-51
Statement of Responsibility
Mathieu Nadeau-Vallée, Dima Obari, Christiane Quiniou, William D.Lubell, David M.Olson, Sylvie Girard, Sylvain Chemtob
Conference Name
Abstract
Preterm birth (PTB) is a leading cause of neonatal mortality and morbidity worldwide, and represents a heavy economic and social burden. Despite its broad etiology, PTB has been firmly linked to inflammatory processes. Pro-inflammatory cytokines are produced in gestational tissues in response to stressors and can prematurely induce uterine activation, which precedes the onset of preterm labor. Of all cytokines implicated, interleukin (IL)-1 has been largely studied, revealing a central role in preterm labor. However, currently approved IL-1-targeting therapies have failed to show expected efficacy in pre-clinical studies of preterm labor. Herein, we (a) summarize animal and human studies in which IL-1 or IL-1-targeting therapeutics are implicated with preterm labor, (b) focus on novel IL-1-targeting therapies and diagnostic tests, and (c) develop the case for commercialization and translation means to hasten their development.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2015 Elsevier Ltd. All rights reserved.